Editing Blood glucose monitoring (section)

==Recommendations==
The [[National Institute for Health and Clinical Excellence]] (NICE), UK released updated diabetes recommendations on 30 May 2008, which recommend that self-monitoring of plasma glucose levels for people with newly diagnosed type 2 diabetes must be integrated into a structured self-management education process.<ref>{{Cite web|url=https://www.nice.org.uk/guidance|title=Find guidance|website=NICE}}</ref> The recommendations have been updated in August 2015 for children and young adults with type 1 diabetes.<ref>{{Cite web|url=https://www.nice.org.uk/guidance/ng18|title=Overview {{!}} Diabetes (type 1 and type 2) in children and young people: diagnosis and management {{!}} Guidance {{!}} NICE|website=www.nice.org.uk|date=August 2015 |access-date=2019-04-25}}</ref>

The [http://www.diabetes.org/ American Diabetes Association (ADA)], which produces guidelines for diabetes care and [[Clinical practice guidelines|clinical practice recommendations]], recently updated its "Standards of Medical Care" in January 2019 to acknowledge that routine self-monitoring of blood glucose in people who are not using insulin is of limited additional clinical benefit.<ref>{{cite journal | title = Standards of Medical Care in Diabetes-2019 | journal = Diabetes Care | volume = 42 | issue = Suppl 1 | pages = S4–S6 | date = January 2019 | pmid = 30559226 | doi = 10.2337/dc19-Srev01 | url = http://care.diabetesjournals.org/content/42/Supplement_1/S4 | doi-access = free }}</ref> A randomized controlled trial evaluated once-daily self-monitoring that included tailored patient messaging and did not show that this strategy led to significant changes in A1C after a year.<ref name="Glucose Self-monitoring in Non-Insu"/>